Search Results 401-410 of 4617 for ✒올인구조대 [원탑보증.com/가입코드 111] 롤비제이솔랭 ✒
Subjects who received at least one GM T cell infusion, will be asked to roll-over to this LTFU protocol upon either premature discontinuation from, or ...
A Study of the Safety and Tolerability of JNJ-55920839, Either as a Single Ascending Dose in Healthy Individuals or as Multiple Doses for Patients who have Mild ...
This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other places in the ...
The purpose of this study is to characterize the safety profile of acalabrutinib and pembrolizumab in subjects with hematologic malignancies. Participation ...
The study will evaluate oral daily administration of eFT508. Treatment and study subject evaluation will be performed in 21-day cycles. Participation ...
Roden AC, Asiedu GB, Regnier AK, Bois MC, Boland JM, Yi ES, Lo YC, Larson NL, Peters KL, Zhu X, Scott JP, Aubry MC, Maleszewski JJ.
The purpose of this study is to assess the effectiveness and safety of pembrolizumab (MK-3475) for the treatment of women with advanced ovarian cancer who have ...
Double your impact on cancer! ... Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge. Give Now.
View past members of Mayo Clinic's Bone Injury and Repair Lab led by Abhishek Chandra, Ph.D., M.S..
... . VID-20164173. Home; Arizona Volunteers. 5X Challenge is here! 5X My Gift! Your gift today can have 5X the impact on AI research and technology.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.